Updates in chemotherapy in the treatment of advanced and recurrent endometrial cancer: 0017

International Journal of Gynecological Cancer

Volumn 15, Issue 2, 2005, Pages 407-408

  McMeekin, D S ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645229437     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.abst_17.x     Document Type: Article

References (3)

1. Fleming G, Brunetto V, Cella D et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial cancer: A Gynecologic Oncology Group study. J Clin Oncol 2004; 22: 2159-66.
2. Weber B, Mayer F, Bougnous P et al. What is the best chemotherapy regimen in advanced or recurrent endometrial carcinoma? Preliminary results. Proc Am Soc Clin Oncol 2003; 22: 453, abstract 1819.
3. Randall M, Brunetto G, Muss H et al. Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. Proc Am Soc Clin Oncol 2003; 22: abstract 3.